These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20424540)

  • 1. Antiplatelet therapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Key messages for clinical practice.
    Leontiadis GI; Tse F; Howden CW
    Pol Arch Med Wewn; 2010 Apr; 120(4):143-7. PubMed ID: 20424540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic procedures in patients under clopidogrel/dual antiplatelet therapy: to do or not to do?
    Abdel Samie A; Theilmann L
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):33-6. PubMed ID: 23539388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary stent management in elective genitourinary surgery.
    Gupta AD; Streiff M; Resar J; Schoenberg M
    BJU Int; 2012 Aug; 110(4):480-4. PubMed ID: 22192977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic procedures in patients under clopidogrel or dual antiplatelet therapy: a survey among German gastroenterologists and current guidelines.
    Abdel Samie A; Theilmann L; Labenz J;
    Z Gastroenterol; 2014 May; 52(5):425-8. PubMed ID: 24824906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
    Dai X; Makaryus AN; Makaryus JN; Jauhar R
    Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulation and antiplatelet therapy, and gastrointestinal endoscopy].
    Székely H; Tulassay Z
    Orv Hetil; 2009 Mar; 150(12):541-8. PubMed ID: 19275971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.
    Becker RC; Scheiman J; Dauerman HL; Spencer F; Rao S; Sabatine M; Johnson DA; Chan F; Abraham NS; Quigley EM;
    Am J Gastroenterol; 2009 Dec; 104(12):2903-17. PubMed ID: 19935784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.
    Becker RC; Scheiman J; Dauerman HL; Spencer F; Rao S; Sabatine M; Johnson DA; Chan F; Abraham NS; Quigley EM; ;
    J Am Coll Cardiol; 2009 Dec; 54(24):2261-76. PubMed ID: 19942393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal bleeding after percutaneous coronary intervention.
    Tanigawa T; Watanabe T; Nadatani Y; Otani K; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Digestion; 2011; 83(3):153-60. PubMed ID: 21266809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.
    Veitch AM; Vanbiervliet G; Gershlick AH; Boustiere C; Baglin TP; Smith LA; Radaelli F; Knight E; Gralnek IM; Hassan C; Dumonceau JM
    Gut; 2016 Mar; 65(3):374-89. PubMed ID: 26873868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on the management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery.
    Franchi F; Rollini F; Angiolillo DJ
    Curr Opin Cardiol; 2014 Nov; 29(6):553-63. PubMed ID: 25144343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy and the risk of bleeding induced by gastrointestinal endoscopic procedures. A systematic review of the literature and recommendations.
    Kimchi NA; Broide E; Scapa E; Birkenfeld S
    Digestion; 2007; 75(1):36-45. PubMed ID: 17429206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.
    Tan VP; Yan BP; Kiernan TJ; Ajani AE
    Cardiovasc Revasc Med; 2009; 10(1):36-44. PubMed ID: 19159853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistaxis as the reason for premature discontinuation of clopidogrel after percutaneous coronary angioplasty with stent implantation.
    Jura-Szołtys E; Chudek J
    Kardiol Pol; 2011; 69(8):817-23. PubMed ID: 21850627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Should platelet inhibitors be discontinued before gastrointestinal endoscopy?].
    Hofstad B; Nesbakken A; Eritsland J; Brørs O; Sandset PM
    Tidsskr Nor Laegeforen; 2008 Nov; 128(21):2440-2. PubMed ID: 19096466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal adverse events after dual antiplatelet therapy: clopidogrel is safer than ticagrelor, but prasugrel data are lacking or inconclusive.
    Serebruany VL; Dinicolantonio JJ; Can MM; Pershukov IV; Kuliczkowski W
    Cardiology; 2013; 126(1):35-40. PubMed ID: 23860246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Should Patients Requiring Dual Antiplatelet Therapy be Managed When Undergoing Elective Endoscopic Gastrointestinal Procedures?
    Sherwood MW; Wang TY; Becker RC
    Curr Treat Options Cardiovasc Med; 2011 Feb; 13(1):46-56. PubMed ID: 21136215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.